Mayne Pharma Group Ltd (MYX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.086x

Based on the latest financial reports, Mayne Pharma Group Ltd (MYX) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$31.98 Million ≈ $22.63 Million USD) by net assets (AU$370.28 Million ≈ $262.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Mayne Pharma Group Ltd for the company's overall valuation and market capitalisation.

Mayne Pharma Group Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Mayne Pharma Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mayne Pharma Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mayne Pharma Group Ltd ranked by their cash flow conversion efficiency. Explore MYX cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Xiongan Kerong Environment Technology Co Ltd SHE:300152	-0.004x
TYM Corporation KO:002900	-0.078x
Able C&C KO:078520	0.077x
Superkrane Mitra Utama Tbk PT JK:SKRN	0.091x
SOHO China Limited F:45S	0.005x
Rockfields Property Indonesia Pt JK:ROCK	0.025x
Ha Tien 1 Cement JSC VN:HT1	0.062x
Slam Corp. NASDAQ:SLAMF	0.032x

Annual Cash Flow Conversion Efficiency for Mayne Pharma Group Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mayne Pharma Group Ltd from 2007 to 2025. View Mayne Pharma Group Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$370.28 Million ≈ $262.00 Million	AU$17.47 Million ≈ $12.36 Million	0.047x	+240.05%
2024-06-30	AU$454.19 Million ≈ $321.37 Million	AU$-15.30 Million ≈ $-10.83 Million	-0.034x	+49.97%
2023-06-30	AU$634.36 Million ≈ $448.85 Million	AU$-42.71 Million ≈ $-30.22 Million	-0.067x	-420.56%
2022-06-30	AU$557.12 Million ≈ $394.20 Million	AU$-7.21 Million ≈ $-5.10 Million	-0.013x	-121.12%
2021-06-30	AU$771.58 Million ≈ $545.94 Million	AU$47.26 Million ≈ $33.44 Million	0.061x	-36.02%
2020-06-30	AU$1.04 Billion ≈ $737.50 Million	AU$99.78 Million ≈ $70.60 Million	0.096x	-8.94%
2019-06-30	AU$1.01 Billion ≈ $717.52 Million	AU$106.61 Million ≈ $75.43 Million	0.105x	+6.87%
2018-06-30	AU$1.24 Billion ≈ $873.95 Million	AU$121.50 Million ≈ $85.97 Million	0.098x	+947.27%
2017-06-30	AU$1.31 Billion ≈ $928.62 Million	AU$-15.24 Million ≈ $-10.78 Million	-0.012x	-108.16%
2016-06-30	AU$376.22 Million ≈ $266.20 Million	AU$53.50 Million ≈ $37.86 Million	0.142x	+104.38%
2015-06-30	AU$322.20 Million ≈ $227.98 Million	AU$22.42 Million ≈ $15.86 Million	0.070x	-57.60%
2014-06-30	AU$159.27 Million ≈ $112.70 Million	AU$26.14 Million ≈ $18.49 Million	0.164x	+189.81%
2013-06-30	AU$120.89 Million ≈ $85.54 Million	AU$6.84 Million ≈ $4.84 Million	0.057x	-87.06%
2012-06-30	AU$30.60 Million ≈ $21.65 Million	AU$13.39 Million ≈ $9.47 Million	0.437x	+158.83%
2011-06-30	AU$24.17 Million ≈ $17.10 Million	AU$4.09 Million ≈ $2.89 Million	0.169x	-57.89%
2010-06-30	AU$25.55 Million ≈ $18.08 Million	AU$10.26 Million ≈ $7.26 Million	0.401x	+186.15%
2009-06-30	AU$7.70 Million ≈ $5.45 Million	AU$-3.59 Million ≈ $-2.54 Million	-0.466x	-76.14%
2008-06-30	AU$11.44 Million ≈ $8.09 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.265x	-209.97%
2007-06-30	AU$14.51 Million ≈ $10.27 Million	AU$-1.24 Million ≈ $-876.47K	-0.085x	--

About Mayne Pharma Group Ltd

AU:MYX Australia Medical Distribution

Market Cap

$174.18 Million

AU$246.17 Million AUD

Market Cap Rank

#17168 Global

#493 in Australia

Share Price

AU$3.03

Change (1 day)

-0.98%

52-Week Range

AU$2.13 - AU$6.30

All Time High

AU$41.75